GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GRAIL (NASDAQ: GRAL), a healthcare company focused on early cancer detection, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Wednesday, January 15 at 9:00 a.m. PT in San Francisco. Interested parties can access both live and replay webcasts through the investor relations section of GRAIL's website at investors.grail.com. The presentation recording will remain available for a minimum of 30 days following the event.
GRAIL (NASDAQ: GRAL), un'azienda sanitaria interessata alla rilevazione precoce del cancro, ha annunciato la sua partecipazione al 43° Annual J.P. Morgan Healthcare Conference. La presentazione è programmata per mercoledì 15 gennaio alle 9:00 a.m. PT a San Francisco. Le parti interessate possono accedere sia alle streaming live che alle registrazioni tramite la sezione delle relazioni con gli investitori sul sito web di GRAIL all'indirizzo investors.grail.com. La registrazione della presentazione rimarrà disponibile per un minimo di 30 giorni dopo l'evento.
GRAIL (NASDAQ: GRAL), una empresa de atención médica centrada en la detección temprana del cáncer, ha anunciado su participación en la 43ª Conferencia Anual de Atención Médica de J.P. Morgan. La presentación está programada para miércoles 15 de enero a las 9:00 a.m. PT en San Francisco. Las partes interesadas pueden acceder tanto a las transmisiones en vivo como a las repeticiones a través de la sección de relaciones con inversores en el sitio web de GRAIL en investors.grail.com. La grabación de la presentación permanecerá disponible durante un mínimo de 30 días después del evento.
GRAIL (NASDAQ: GRAL), 조기 암 발견에 중점을 둔 의료 회사가 제43회 J.P. Morgan 의료 회의에 참여한다고 발표했습니다. 발표는 1월 15일 수요일 오전 9:00 PT에 샌프란시스코에서 예정되어 있습니다. 관심 있는 당사자들은 GRAIL의 웹사이트 투자자 관계 섹션인 investors.grail.com을 통해 라이브 및 재생 웹캐스트에 접근할 수 있습니다. 발표 녹화는 이벤트 종료 후 최소 30일 동안 이용 가능합니다.
GRAIL (NASDAQ: GRAL), une entreprise de santé axée sur la détection précoce du cancer, a annoncé sa participation à la 43e Conférence Annuelle de J.P. Morgan Santé. La présentation est prévue pour mercredi 15 janvier à 9h00 PT à San Francisco. Les parties intéressées peuvent accéder à la fois aux webcasts en direct et aux rediffusions via la section des relations avec les investisseurs sur le site internet de GRAIL à l'adresse investors.grail.com. L'enregistrement de la présentation restera disponible pendant un minimum de 30 jours après l'événement.
GRAIL (NASDAQ: GRAL), ein im Bereich der Gesundheitsversorgung tätiges Unternehmen, das sich auf die frühzeitige Krebsdiagnose spezialisiert hat, hat seine Teilnahme an der 43. J.P. Morgan Healthcare Conference angekündigt. Die Präsentation ist für Mittwoch, den 15. Januar um 9:00 Uhr PT in San Francisco angesetzt. Interessierte Parteien können sowohl über Live- als auch über Replay-Webcasts über den Bereich Investor Relations auf der Website von GRAIL unter investors.grail.com darauf zugreifen. Die Aufzeichnung der Präsentation bleibt für mindestens 30 Tage nach der Veranstaltung verfügbar.
- None.
- None.
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302335384.html
SOURCE GRAIL, Inc.
FAQ
When is GRAIL (GRAL) presenting at the 2024 J.P. Morgan Healthcare Conference?
How can investors watch GRAIL's (GRAL) J.P. Morgan Healthcare Conference presentation?
How long will GRAIL's (GRAL) J.P. Morgan Healthcare Conference presentation be available for replay?
What is GRAIL's (GRAL) main business focus?
